An update from Allarity Therapeutics, Inc. (ALLR) is now available.
Allarity Therapeutics, Inc. has announced that they have successfully met NASDAQ’s Minimum Bid Price Requirement, ensuring their continued compliance with the stock market’s standards. This development, which is significant for the company’s financial health and investor confidence, has been officially shared in a press release but is not considered filed for legal purposes unless expressly stated in future documents.
Learn more about ALLR stock on TipRanks’ Stock Analysis page.
